InsidersTradesSigma
天臣医疗 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Follow the 天臣医疗 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 天臣医疗 has recorded 11 insider filings. Market capitalisation: €3.9bn. The latest transaction was reported on 27 January 2026 (Sale). Among the most active insiders: 丁水澄. Every trade is accessible without an account.
11
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
10 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,044 of 25,837 companies
61.1
score / 100
Value40
Quality82
FCF yld-0.9%
Earn yld4.3%
EV/EBITDA18.8x
ROE14%
Gross mgn64%
Net mgn26%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 27 January 2026
Declarations11 total
11 of 11 declarations